{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_codes_comments in Code Comments (approximate match)
Status:
Possibly Marketed Outside US
Source:
21 CFR 333C
(2013)
Source URL:
First approved in 2001
Source:
M017
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
NCT00790140: Phase 4 Interventional Unknown status Esophageal Cancer
(2005)
Source URL:
First approved in 1984
Source:
NeuroBion by BENARD INDUSTRIES INC
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
FLUIDBASE AHA 10 by LABORATORIO GENOVE S.A.
(2016)
Source URL:
First approved in 1983
Source:
NDA018861
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
First approved in 1950
Source:
NDA007073
Source URL:
Class:
POLYMER
Cellacefate is a commonly used polymer phthalate in the formulation of pharmaceuticals, such as the enteric coating of tablets or capsules and for controlled release formulations. Cellacefate's use in enteric coatings allows tablets to remain intact in the unfavorable gastric acid secretion of the stomach, but dissolve in the more basic areas of the duodenum, thus protecting the stomach from ulceration or allowing greater absorption form the duodenum. Cellacefate is a reaction product of phthalic anhydride and a partial acetate ester of cellulose.
Status:
Possibly Marketed Outside US
Source:
Canada:MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A
Source URL:
Class:
POLYMER
Status:
US Approved Rx
(1996)
First approved in 1995
Class:
STRUCTURALLY DIVERSE
Status:
First approved in 1963
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 347.10(f) skin protectant colloidal oatmeal
Source URL:
First approved in 1987
Source:
M016
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 346.14(a)(7) anorectal:protectant mineral oil
Source URL:
First marketed in 1921
Source:
Liquid Petrolatum U.S.P.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
US Approved OTC
Source:
21 CFR 349.14(b)(4) ophthalmic:emollient petrolatum
Source URL:
First marketed in 1921
Class:
STRUCTURALLY DIVERSE
